A Clinical Trial to Evaluate the Effects of Super Liver Liquid Drops on Gut Health, Digestive Comfort, and Daily Energy Levels

NCT07742657 | Active Not Recruiting

• 1 other identifier: SUPER-30544
• Study Type: interventional
• Target: 35
• Locations: 1 country
• Sites: 1

Brief Summary

This is a decentralized (fully virtual), single-group, open-label, prospective clinical trial evaluating the effects of Super Liver Liquid Drops, a liquid botanical dietary supplement, on gut health, digestive comfort, energy levels, and overall well-being over 12 weeks. All 35 enrolled participants will self-administer 2 mL of Super Liver Liquid Drops daily (2 droppers filled to 1 mL each) in the morning with breakfast for the full 12-week intervention period. Participants will complete validated questionnaires and self-reported assessments at Baseline, Week 2, Week 4, Week 8, and Week 12 via the Citruslabs study platform. All study activities will be conducted remotely.

Conditions

Gastrointestinal Symptoms; Digestive Discomfort; Low Energy Levels; Brain Fog; Mood Instability; Skin Clarity; Facial Puffiness; Bad Breath; Bloating; Sleep Quality

Outcome Measures

Primary Outcomes (1)

• Change in Gastrointestinal Symptom Rating Scale (GSRS)

  Change from baseline to Week 12 in gastrointestinal symptom severity as assessed by the Gastrointestinal Symptom Rating Scale (GSRS). Higher scores indicate greater gastrointestinal symptom severity.

  Baseline to Week 12

Secondary Outcomes (6)

• Change in Self-Reported Energy Level Score

  Baseline to Week 12

• Change in Self-Reported Brain Fog Score

  Baseline to Week 12

• Change in Self-Reported Mood Stability Score

  Baseline to Week 12

• Change in Self-Reported Sleep Quality Score

  Baseline to Week 12

• Change in Self-Reported Skin Clarity Score

  Baseline to Week 12

Study Arms (1)

Super Liver Arm

EXPERIMENTAL

Dietary Supplement: Super Liver

Interventions

Super Liver DIETARY_SUPPLEMENT

All 35 enrolled participants self-administer 2 mL of Super Liver Liquid Drops daily (2 droppers filled to 1 mL each), taken in the morning with breakfast, for 12 consecutive weeks.

Super Liver Arm

Eligibility Criteria

• Age: 30 Years - 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Be male or female.
• Be aged 30-65 years (inclusive) at the time of enrollment.
• Over the past four weeks, has had concerns regarding low energy levels and at least two of the following: Bloating, Digestion, Irregular Bowel movements, Brain fog.
• Anyone who is generally healthy - does not live with any uncontrolled chronic disease.
• Willing and able to follow the study protocol as described.
• Willing to maintain their current diet, exercise routine, and sleep patterns, for the duration of the trial.
• If taking other over-the-counter supplements or herbal remedies is willing to maintain this routine without introducing any other new products for the study duration.
• Resides in the United States.
• Willing to follow the study protocol as described.

You may not qualify if:

• Known allergy or sensitivity to any of the study product ingredients (milk thistle, dandelion, yellow dock, turmeric, ginger, chicory/inulin, berberine).
• Known history of severe digestive disorders like acid reflux, Irritable Bowel Syndrome (IBS), Irritable Bowel Disease (IBD), Crohn's disease, or gastrointestinal tract surgeries.
• Known history of gallbladder disease or bile duct obstruction.
• Has a chronic health condition that could impact participation in this study, such as oncological or psychiatric disorders.
• Has a planned surgery in the next 12 weeks.
• Currently pregnant, breastfeeding, or planning to become pregnant during the study period.
• Known history of substance abuse.
• Currently, or was in the past 3 months, a smoker.
• Currently participating in or planning to participate in another research study during the study period.

Sponsors & Collaborators

• SuperBonsai Inc.: lead
• Citruslabs: collaborator

Study Sites (1)

Citruslabs

Las Vegas, Nevada, 89118, United States

Location

MeSH Terms

Conditions

Mental Fatigue; Sleep Initiation and Maintenance Disorders; Halitosis

Condition Hierarchy (Ancestors)

Fatigue; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Behavioral Symptoms; Behavior; Sleep Disorders, Intrinsic; Dyssomnias; Sleep Wake Disorders; Nervous System Diseases; Mental Disorders; Signs and Symptoms, Digestive

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 6, 2026
• First Posted: August 3, 2026
• Study Start: June 24, 2026
• Primary Completion (Estimated): September 1, 2026
• Study Completion (Estimated): September 1, 2026
• Last Updated: August 3, 2026

Record last verified: 2026-07

Locations

US (1)